Log In
Print
BCIQ
Print
Print this Print this
 

GV2311

Also known as: RSV vaccine

  Manage Alerts
Collapse Summary General Information
Company GenVec Inc.
DescriptionHuman adenovirus vector vaccine against respiratory syncytial virus (RSV)
Molecular Target
Mechanism of ActionGene therapy
Therapeutic ModalityGene therapy: Viral vector
Latest Stage of DevelopmentPreclinical
Standard IndicationRespiratory syncytial virus (RSV)
Indication DetailsPrevent respiratory syncytial virus (RSV)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today